NCT03496688 is a NA clinical trial of Sinus floor augmentation in Atrophy, sponsored by University of Roma La Sapienza.

Who is sponsoring NCT03496688?

NCT03496688 is sponsored by University of Roma La Sapienza.

What drugs are being tested in NCT03496688?

Interventions in NCT03496688: Sinus floor augmentation.

What condition does NCT03496688 study?

NCT03496688 studies Atrophy, Jaw, Edentulous, Partially, Sinus Floor Augmentation, Bone Substitutes, Bone Regeneration.

Is NCT03496688 still recruiting?

NCT03496688 is currently completed. Last updated 12 April 2018.

Last reviewed 2018-04-12 · How we verify

NCT03496688

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus

Completed NA Last updated 12 April 2018

What this trial tests

NA trial testing Sinus floor augmentation in Atrophy in 6 participants. Completed in 11 September 2017.

Timeline

12 January 2015

Primary endpoint
4 January 2016

11 September 2017

Quick facts

Lead sponsor	University of Roma La Sapienza
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	6
Start date	12 January 2015
Primary completion	4 January 2016
Estimated completion	11 September 2017

Drugs / interventions tested

Sinus floor augmentation

Conditions studied

Atrophy — all drugs for Atrophy →
Jaw, Edentulous, Partially — all drugs for Jaw, Edentulous, Partially →
Sinus Floor Augmentation — all drugs for Sinus Floor Augmentation →
Bone Substitutes — all drugs for Bone Substitutes →

Sponsor

University of Roma La Sapienza

Who can join

Adults 33 to 70, any sex, with Atrophy or Jaw, Edentulous, Partially. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: The aim of the study was to compare histological and histomorphometric results of six bone substitute materials used as graft in two-stage maxillary sinus augmentation model, after 6-month-healing.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Comparative Histological and Histomorphometric Results of Six Biomaterials Used in Two-Stage Maxillary Sinus Augmentation Model after 6-Month Healing.
La Monaca G, Iezzi G, Cristalli MP, Pranno N, et al · · 2018 · cited 34× · PMID 30050947 · DOI 10.1155/2018/9430989
Biomimetic Aspects of Oral and Dentofacial Regeneration.
Upadhyay A, Pillai S, Khayambashi P, Sabri H, et al · · 2020 · cited 15× · PMID 33053903 · DOI 10.3390/biomimetics5040051

Verify or expand the search:

Other trials of Sinus floor augmentation

Trials testing the same drug.

NCT04543630 — Maxillary Sinus Floor Augmentation in Diabetic Patients · NA · not yet recruiting
NCT05577520 — Maxillary Sinus Augmentation Using Different Size Bovine Bone Particles · NA · completed

Other recruiting trials for Atrophy

Currently open trials in the same condition.

NCT05698316 — A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Predicti · active not recruiting
NCT05626855 — Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab · Phase 3 · active not recruiting

Other University of Roma La Sapienza trials

Trials by the same sponsor.

NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03496688 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
Last refreshed: 12 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03496688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing